Search Ontology:
ChEBI
N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol
- Term ID
- CHEBI:63988
- Synonyms
-
- 1-phenyl-3-prop-2-en-1-yl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
- 3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
- 3-Allyl-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
- N-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine
- SK&F 77434
- SKF 77434
- Skf-77434
- Definition
- A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1, an allyl substituent at position 3 and two hydroxy substituents at positions 7 and 8. Selective dopamine D1-like receptor partial agonist (IC50 values are 19.7 and 2425 nM for binding to D1-like and D2-like receptors respectively). Centrally active following systemic administration in vivo.
- References
-
- CAS:104422-04-0
- LINCS:LSM-1702
- Reaxys:1546935
- Wikipedia:SKF-77434
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol
Phenotype where environments contain N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol
Phenotype modified by environments containing N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol
Human Disease Model